SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-040982
Filing Date
2017-08-08
Accepted
2017-08-08 06:03:21
Documents
50
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471369_10q.htm 10-Q 387539
2 EXHIBIT 31.1 v471369_ex31-1.htm EX-31.1 9223
3 EXHIBIT 31.2 v471369_ex31-2.htm EX-31.2 9519
4 EXHIBIT 32.1 v471369_ex32-1.htm EX-32.1 4292
  Complete submission text file 0001144204-17-040982.txt   3110029

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20170630.xml EX-101.INS 611950
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20170630.xsd EX-101.SCH 33929
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20170630_cal.xml EX-101.CAL 25117
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20170630_def.xml EX-101.DEF 203342
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20170630_lab.xml EX-101.LAB 243698
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20170630_pre.xml EX-101.PRE 236576
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 171013130
SIC: 2834 Pharmaceutical Preparations